Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
The Board Of Supervisors Of Lousiana State University And Agricultural And Mechanical College currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This prosecution activity is handled by 1 distinct examiner and 1 distinct art unit. The busiest examiner for this portfolio is PALLAY, MICHAEL B, who is responsible for 1 busiest examiner pending office action.
With 1 distinct examiner and 1 distinct art unit, the 1 pending office action is subject to a single point of review. Practitioners should address the specific requirements of PALLAY, MICHAEL B, who holds the 1 busiest examiner pending office action. The Biotechnology & Pharmaceuticals technology area provides the technical and regulatory framework for this specific filing.
The outcome of the prosecution depends on the interpretation of the assigned examiner. Practitioners can focus on the standards of the specific art unit involved without the need to coordinate across different departments. This structure allows for a strategy directed at the individual examiner feedback rather than managing multiple viewpoints.
Administrative tasks are limited by the number of active examiners and art units. Efforts should be made to understand the examiner review style and past actions. Communication with the assigned individual is a method for navigating the current prosecution phase and resolving the outstanding action.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PALLAY, MICHAEL B | 1 | 55.8% | +34.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17909869 | ANTISEPTIC-ANTIBIOTIC GUMBOS EFFECTIVE AGAINST GRAM-NEGATIVE PATHOGENS | PALLAY, MICHAEL B | 34d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17909869 | ANTISEPTIC-ANTIBIOTIC GUMBOS EFFECTIVE AGAINST GRAM-NEGATIVE PATHOGENS | PALLAY, MICHAEL B | 34d |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17909869 | ANTISEPTIC-ANTIBIOTIC GUMBOS EFFECTIVE AGAINST GRAM-NEGATIVE PATHOGENS | PALLAY, MICHAEL B | 1617 | §103§112 | Non-Final OA | 34d | Pending | Sep 07, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial